查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1830901

2025年全球体细胞基因检测市场报告

Somatic Genetic Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，体细胞基因检测市场发展迅速，预计从2024年的68.1亿美元成长到2025年的77.8亿美元，复合年增长率达14.3%。这一增长可归因于人们对遗传疾病的认识不断提高、癌症发病率上升、临床环境中基因检测的普及、医疗基础设施的扩建以及患者对个人化治疗需求的增加。

预计未来几年体细胞基因检测市场将快速成长，到2029年市场规模将达到131.3亿美元，年复合成长率（CAGR）为14.0%。预测期内的成长可归因于对疾病早期检测的日益重视、生物技术公司和製药公司之间合作的加强、官民合作关係的增多以及先进诊断工具的日益普及。这段时期的主要趋势包括定序技术的进步、生物资讯学和人工智慧的创新、研发投入的增加、非侵入性检测方法的进步以及次世代定序平台的持续创新。

体细胞基因检测是对人类一生中非生殖细胞（体细胞）中发生的基因突变进行全面分析，其中许多突变发生在肿瘤组织中。体细胞基因检测透过检测可作为个人化治疗标靶的特定基因改变，以及预测疾病进展和支持临床决策，在癌症诊断和治疗中发挥重要作用。

体细胞基因检测的主要类型包括标靶基因panel检测、全外EXOME定序、全基因测序和带因者筛检。标靶基因panel检测透过分析与特定疾病或病症相关的特定基因集，实现准确且经济高效的诊断。这些检测可使用多种样本类型，包括组织样本、血液样本和骨髓穿刺液。它们采用聚合酵素链锁反应(PCR)、次世代定序(NGS)、微阵列和桑格定序等先进技术。这些检测应用于癌症诊断、心血管疾病、神经系统疾病和遗传性疾病等多个领域，并被医院、临床实验室、研究机构和家庭检测服务提供者等终端用户所使用。

美国2025年突然提高关税及其引发的贸易摩擦正对製药公司造成严重衝击。利润丰厚的学名药生产商尤其脆弱，一些公司不得不缩减低利润药物的生产规模。生物技术公司也因关税导致的专用试剂短缺而面临临床试验延期。为因应这一局面，製药业正在印度和欧洲扩大原料药的生产，增加库存，并游说政府对基本药物给予贸易豁免。

这份体细胞基因检测市场研究报告是商业研究公司最新报告系列的一部分，提供体细胞基因检测市场统计数据，包括全球市场规模、区域份额、竞争对手及其市场份额、详细的市场细分、市场趋势以及体细胞基因检测行业的商机。本市场研究报告对该行业的现状和未来发展趋势进行了深入分析，为您提供所需的一切全面观点。

预计未来几年癌症发生率的上升将推动体细胞基因检测市场的成长。癌症是一组以体内异常细胞不受控制地生长和扩散为特征的疾病。癌症负担的加重与不健康的饮食、吸烟、缺乏运动和过量饮酒等生活方式因素密切相关。体细胞基因检测透过识别肿瘤特异性基因突变来辅助癌症诊断，从而实现标靶和个人化的治疗策略。先进技术还能减少侵入性手术的需求，提高诊断准确性，并改善病患预后。例如，澳洲政府机构—澳洲健康与福利研究所（Australian Institute of Health and Welfare）于2024年7月报告称，2022年澳洲确诊癌症患者人数达到160,570人，比2021年的156,781人增加了3,789人。因此，癌症发生率的上升正在刺激对体细胞基因检测的需求。

体细胞基因检测市场的企业正致力于开发先进的诊断解决方案，例如液态切片活检，以提高检测准确性、实现早期发现并减少对侵入性操作的依赖。液态切片是一种非侵入性方法，用于分析血液样本中的循环肿瘤DNA (ctDNA) 和其他生物标记物，以识别癌症相关的基因突变。例如，2024年9月，印度基因组学和生物资讯学公司Strand Life Sciences推出了Somatic Advantage 74液体活检 (SA74 LB) 检测，这是一种基于新一代次世代定序仪(NGS) 的解决方案，旨在检测血液样本中的ctDNA。此检测可识别74个关键癌症相关基因中的体细胞突变，透过精确定位可操作的突变、监测治疗反应以及检测微量残存疾病(MRD)，无需传统的组织切片检查，从而支持个人化癌症治疗。此外，它还能指导标靶治疗并即时追踪疾病进展和抗药性，从而推动精准肿瘤学的发展。

2022年12月，中国基因检测公司普瑞纳斯环球有限公司（Prenetics Global Limited）收购了ACT Genomics Holdings Company，具体金额未揭露。此次收购使普瑞纳斯环球有限公司获得了ACT Genomics的癌症检测技术，包括新一代定序（NGS）、生物资讯学和基因组分析，从而增强了细胞株和细胞株检测能力。总部位于台湾的ACT Genomics Holdings Company Limited专注于为癌症患者提供体细胞基因检测服务。

体细胞基因检测市场由提供肿瘤谱分析、生物标记鑑定、伴随诊断检测、突变分析以及用于个人化癌症治疗方案选择和治疗监测的次世代定序(NGS) 等服务的营业单位所获得的收入组成。市场价值包括服务供应商销售的任何相关产品或包含在其服务产品中的任何相关产品的价值。体细胞基因检测市场还包括用于检测和解读体细胞突变的检测套组、试剂、检测组合、定序仪、数据分析软体工具和实验室耗材的销售。该市场的价值为“出厂价”，即产品製造商或创建者销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的产品价值。该市场的产品价值还包括产品创建者销售的任何相关服务的价值。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球体细胞基因检测：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 终端用户产业分析
  • 全球体细胞基因检测市场：成长率分析
  • 全球体细胞基因检测市场表现：规模与成长，2019-2024年
  • 全球体细胞基因检测市场预测：规模与成长，2024-2029年，2034年
  • 全球体细胞基因检测：潜在市场规模（TAM）

第六章 市场细分

  • 全球体细胞基因检测市场按类型、效能和预测划分，2019-2024年、2024-2029年、2034年
  • 标靶基因检测
  • 全EXOME定序
  • 全基因测序
  • 携带者筛检
  • 其他的
  • 全球体细胞基因检测市场：依样本类型、表现及预测划分，2019-2024年、2024-2029年、2034年
  • 组织
  • 血
  • 骨髓穿刺液
  • 其他的
  • 全球体细胞基因检测市场：依技术、效能和预测划分，2019-2024年、2024-2029年、2034年
  • 聚合酵素链锁反应（PCR）
  • 次世代定序（NGS）
  • 微阵列
  • 桑格定序
  • 其他的
  • 全球体细胞基因检测市场：依应用、效能和预测划分，2019-2024年、2024-2029年、2034年
  • 癌症诊断
  • 心血管疾病
  • 神经系统疾病
  • 遗传性疾病
  • 其他的
  • 全球体细胞基因检测市场依最终用户、效能和预测划分，2019-2024年、2024-2029年、2034年
  • 医院
  • 临床实验室
  • 研究所
  • 居家检测服务提供者
  • 其他的
  • 全球体细胞基因检测市场：靶向基因panel细分市场，按类型、性能和预测（2019-2024年、2024-2029年、2034年）
  • 肿瘤专家组
  • 神经科专家组
  • 心血管专家组
  • 罕见疾病专家组
  • 药物基因组学小组
  • 全球体细胞基因检测市场：全EXOME定序细分市场，按类型、表现和预测，2019-2024年、2024-2029年、2034年
  • 诊断性全EXOME定序
  • 全外EXOME定序在临床研究的应用
  • 基于人群的全EXOME定序
  • 全球体细胞基因检测市场：全基因测序细分市场，按类型、表现和预测，2019-2024年、2024-2029年、2034年
  • 临床全基因测序
  • 全基因测序研究
  • De Novo 全基因测序
  • 癌症全基因测序
  • 全球体细胞基因检测市场：带因者筛检细分市场，按类型、表现和预测（2019-2024年、2024-2029年、2034年）
  • 扩大携带者筛检
  • 基于种族的携带者筛检
  • 普遍携带者筛检
  • 全球体细胞基因检测市场：其他细分市场、按类型划分、实际结果和预测（2019-2024年、2024-2029年、2034年）
  • 拷贝数变异测试
  • 粒线体去氧核糖核酸（DNA）检测
  • 核糖核酸（RNA）定序
  • 表观遗传学检测

第七章 区域和国家分析

  • 全球体细胞基因检测市场：依地区、绩效及预测划分，2019-2024年、2024-2029年、2034年
  • 全球体细胞基因检测市场：国家、市场表现及预测，2019-2024年、2024-2029年、2034年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 体细胞基因检测市场：竞争格局
  • 体细胞基因检测市场：公司概况
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
    • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Illumina Inc.
  • QIAGEN NV
  • Exact Sciences Corp.
  • ARUP Laboratories Inc.
  • Natera Inc.
  • Myriad Genetics Inc.
  • Fulgent Genetics Inc.
  • Invitae Corporation
  • NeoGenomics Laboratories Inc.
  • Guardant Health Inc.
  • MedGenome Labs Ltd.
  • Caris Life Sciences Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California Inc.
  • Invivoscribe Inc.

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年体细胞基因检测市场：提供新机会的国家
  • 2029年体细胞基因检测市场：新兴细分市场机会
  • 2029年体细胞基因检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r37892

Somatic genetic testing refers to the comprehensive analysis of genetic mutations that occur in non-reproductive (somatic) cells over a person's lifetime, most often within tumor tissues. It plays a vital role in cancer diagnosis and treatment by detecting specific genetic alterations that can be targeted with personalized therapies, while also helping to predict disease progression and support clinical decision-making.

The key types of somatic genetic testing include targeted gene panels, whole exome sequencing, whole genome sequencing, carrier screening, and others. Targeted gene panels involve analyzing a defined group of genes linked to a particular disease or condition, allowing for accurate and cost-effective diagnosis. This testing can be performed using a range of sample types, such as tissue-based samples, blood samples, bone marrow aspirates, and others. It employs advanced technologies including polymerase chain reaction (PCR), next-generation sequencing (NGS), microarray, Sanger sequencing, and more. Somatic genetic testing is applied in various areas such as cancer diagnosis, cardiovascular diseases, neurological disorders, inherited genetic conditions, and others, and is utilized by end users including hospitals, clinical laboratories, research institutes, at-home testing providers, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The somatic genetic testing market research report is one of a series of new reports from The Business Research Company that provides somatic genetic testing market statistics, including somatic genetic testing industry global market size, regional shares, competitors with a somatic genetic testing market share, detailed somatic genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the somatic genetic testing industry. This somatic genetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The somatic genetic testing market size has grown rapidly in recent years. It will grow from $6.81 billion in 2024 to $7.78 billion in 2025 at a compound annual growth rate (CAGR) of 14.3%. The growth during the historic period can be attributed to increasing awareness of genetic disorders, the rising prevalence of cancer, greater adoption of genetic testing in clinical settings, the expansion of healthcare infrastructure, and growing patient demand for personalized treatment.

The somatic genetic testing market size is expected to see rapid growth in the next few years. It will grow to $13.13 billion in 2029 at a compound annual growth rate (CAGR) of 14.0%. The growth in the forecast period can be attributed to the increasing focus on early disease detection, rising collaborations between biotechnology and pharmaceutical companies, the expansion of public-private partnerships, and greater availability of advanced diagnostic tools. Key trends expected during this period include technological progress in sequencing, innovations in bioinformatics and artificial intelligence, increased investment in research and development, the advancement of non-invasive testing methods, and continued innovations in next-generation sequencing platforms.

The rising incidence of cancer is expected to drive the growth of the somatic genetic testing market in the coming years. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. The increasing burden of cancer is linked to lifestyle factors such as unhealthy diets, smoking, physical inactivity, and excessive alcohol consumption. Somatic genetic testing supports cancer diagnosis by identifying tumor-specific genetic mutations, enabling targeted and personalized treatment strategies. It also reduces the need for invasive procedures through advanced technologies, enhancing diagnostic accuracy and improving patient outcomes. For example, in July 2024, the Australian Institute of Health and Welfare, a government agency, reported that the number of cancer cases diagnosed in Australia reached 160,570 in 2022, an increase of 3,789 cases from 156,781 in 2021. Consequently, the growing incidence of cancer is fueling demand for somatic genetic testing.

Companies in the somatic genetic testing market are focusing on advanced diagnostic solutions such as liquid biopsy tests to improve precision, enable early detection, and reduce reliance on invasive procedures. Liquid biopsy refers to a non-invasive method of analyzing circulating tumor DNA (ctDNA) or other biomarkers in blood samples to identify cancer-related genetic mutations. For instance, in September 2024, Strand Life Sciences, an India-based genomics and bioinformatics company, introduced the Somatic Advantage 74 Liquid Biopsy (SA74 LB) test, a next-generation sequencing (NGS)-based solution designed to detect ctDNA from blood samples. This test identifies somatic mutations across 74 key cancer-related genes, supporting personalized cancer care by pinpointing actionable mutations, monitoring treatment response, and detecting minimal residual disease (MRD) without traditional tissue biopsies. It facilitates precision oncology by guiding targeted therapies and tracking disease progression or resistance in real time.

In December 2022, Prenetics Global Limited, a China-based genetic testing company, acquired ACT Genomics Holdings Company Limited for an undisclosed sum. Through this acquisition, Prenetics gains access to ACT Genomics' cancer testing technologies, including NGS, bioinformatics, and genome profiling, to enhance both somatic and germline testing across Asia and beyond. ACT Genomics Holdings Company Limited, based in Taiwan, specializes in somatic genetic testing for cancer patients.

Major players in the somatic genetic testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Exact Sciences Corp., ARUP Laboratories Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., MedGenome Labs Ltd., Caris Life Sciences Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Invivoscribe Inc., Centogene N.V., and Circulogene Theranostics LLC.

North America was the largest region in the somatic genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in somatic genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the somatic genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The somatic genetic testing market consists of revenues earned by entities by providing services such as tumor profiling, biomarker identification, companion diagnostic testing, mutation analysis, and next-generation sequencing (NGS) for personalized cancer therapy selection and treatment monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The somatic genetic testing market also includes sales of testing kits, reagents, assay panels, sequencing instruments, software tools for data analysis, and laboratory consumables used in the detection and interpretation of somatic mutations. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Somatic Genetic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on somatic genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for somatic genetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The somatic genetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Targeted Gene Panels; Whole Exome Sequencing; Whole Genome Sequencing; Carrier Screening; Other Testing Methods
  • 2) By Sample: Tissue-Based; Blood-Based; Bone Marrow Aspirates; Other Samples
  • 3) By Technology: Polymerase Chain Reaction (PCR); Next-Generation Sequencing (NGS); Microarray; Sanger Sequencing; Other Technologies
  • 4) By Application: Cancer Diagnosis; Cardiovascular Disorders; Neurological Disorders; Inherited Genetic Disorders; Other Applications
  • 5) By End-User: Hospitals; Clinical Laboratories; Research Institutes; At-Home Testing Providers; Other End-Users
  • Subsegments:
  • 1) By Targeted Gene Panels: Oncology Panels; Neurology Panels; Cardiovascular Panels; Rare Disease Panels; Pharmacogenomics Panels
  • 2) By Whole Exome Sequencing: Diagnostic Whole Exome Sequencing; Clinical Research Whole Exome Sequencing; Population-Based Whole Exome Sequencing
  • 3) By Whole Genome Sequencing: Clinical Whole Genome Sequencing; Research Whole Genome Sequencing; De Novo Whole Genome Sequencing; Cancer Whole Genome Sequencing
  • 4) By Carrier Screening: Expanded Carrier Screening; Ethnicity-Based Carrier Screening; Universal Carrier Screening
  • 5) By Other Testing Methods: Copy Number Variation Testing; Mitochondrial Deoxyribonucleic Acid (DNA) Testing; Ribonucleic Acid (RNA) Sequencing; Epigenetic Testing
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Agilent Technologies Inc.; Illumina Inc.; QIAGEN N.V.; Exact Sciences Corp.; ARUP Laboratories Inc.; Natera Inc.; Myriad Genetics Inc.; Fulgent Genetics Inc.; Invitae Corporation; NeoGenomics Laboratories Inc.; Guardant Health Inc.; MedGenome Labs Ltd.; Caris Life Sciences Inc.; Oxford Nanopore Technologies Ltd.; Pacific Biosciences of California Inc.; Invivoscribe Inc.; Centogene N.V.; Circulogene Theranostics LLC.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Somatic Genetic Testing Market Characteristics

3. Somatic Genetic Testing Market Trends And Strategies

4. Somatic Genetic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Somatic Genetic Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Somatic Genetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Somatic Genetic Testing Market Growth Rate Analysis
  • 5.4. Global Somatic Genetic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Somatic Genetic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Somatic Genetic Testing Total Addressable Market (TAM)

6. Somatic Genetic Testing Market Segmentation

  • 6.1. Global Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Targeted Gene Panels
  • Whole Exome Sequencing
  • Whole Genome Sequencing
  • Carrier Screening
  • Other Testing Methods
  • 6.2. Global Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tissue-Based
  • Blood-Based
  • Bone Marrow Aspirates
  • Other Samples
  • 6.3. Global Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction (PCR)
  • Next-Generation Sequencing (NGS)
  • Microarray
  • Sanger Sequencing
  • Other Technologies
  • 6.4. Global Somatic Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer Diagnosis
  • Cardiovascular Disorders
  • Neurological Disorders
  • Inherited Genetic Disorders
  • Other Applications
  • 6.5. Global Somatic Genetic Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinical Laboratories
  • Research Institutes
  • At-Home Testing Providers
  • Other End-Users
  • 6.6. Global Somatic Genetic Testing Market, Sub-Segmentation Of Targeted Gene Panels, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology Panels
  • Neurology Panels
  • Cardiovascular Panels
  • Rare Disease Panels
  • Pharmacogenomics Panels
  • 6.7. Global Somatic Genetic Testing Market, Sub-Segmentation Of Whole Exome Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Whole Exome Sequencing
  • Clinical Research Whole Exome Sequencing
  • Population-Based Whole Exome Sequencing
  • 6.8. Global Somatic Genetic Testing Market, Sub-Segmentation Of Whole Genome Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinical Whole Genome Sequencing
  • Research Whole Genome Sequencing
  • De Novo Whole Genome Sequencing
  • Cancer Whole Genome Sequencing
  • 6.9. Global Somatic Genetic Testing Market, Sub-Segmentation Of Carrier Screening, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Expanded Carrier Screening
  • Ethnicity-Based Carrier Screening
  • Universal Carrier Screening
  • 6.10. Global Somatic Genetic Testing Market, Sub-Segmentation Of Other Testing Methods, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Copy Number Variation Testing
  • Mitochondrial Deoxyribonucleic Acid (DNA) Testing
  • Ribonucleic Acid (RNA) Sequencing
  • Epigenetic Testing

7. Somatic Genetic Testing Market Regional And Country Analysis

  • 7.1. Global Somatic Genetic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Somatic Genetic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Somatic Genetic Testing Market

  • 8.1. Asia-Pacific Somatic Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Somatic Genetic Testing Market

  • 9.1. China Somatic Genetic Testing Market Overview
  • 9.2. China Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Somatic Genetic Testing Market

  • 10.1. India Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Somatic Genetic Testing Market

  • 11.1. Japan Somatic Genetic Testing Market Overview
  • 11.2. Japan Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Somatic Genetic Testing Market

  • 12.1. Australia Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Somatic Genetic Testing Market

  • 13.1. Indonesia Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Somatic Genetic Testing Market

  • 14.1. South Korea Somatic Genetic Testing Market Overview
  • 14.2. South Korea Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Somatic Genetic Testing Market

  • 15.1. Western Europe Somatic Genetic Testing Market Overview
  • 15.2. Western Europe Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Somatic Genetic Testing Market

  • 16.1. UK Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Somatic Genetic Testing Market

  • 17.1. Germany Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Somatic Genetic Testing Market

  • 18.1. France Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Somatic Genetic Testing Market

  • 19.1. Italy Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Somatic Genetic Testing Market

  • 20.1. Spain Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Somatic Genetic Testing Market

  • 21.1. Eastern Europe Somatic Genetic Testing Market Overview
  • 21.2. Eastern Europe Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Somatic Genetic Testing Market

  • 22.1. Russia Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Somatic Genetic Testing Market

  • 23.1. North America Somatic Genetic Testing Market Overview
  • 23.2. North America Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Somatic Genetic Testing Market

  • 24.1. USA Somatic Genetic Testing Market Overview
  • 24.2. USA Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Somatic Genetic Testing Market

  • 25.1. Canada Somatic Genetic Testing Market Overview
  • 25.2. Canada Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Somatic Genetic Testing Market

  • 26.1. South America Somatic Genetic Testing Market Overview
  • 26.2. South America Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Somatic Genetic Testing Market

  • 27.1. Brazil Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Somatic Genetic Testing Market

  • 28.1. Middle East Somatic Genetic Testing Market Overview
  • 28.2. Middle East Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Somatic Genetic Testing Market

  • 29.1. Africa Somatic Genetic Testing Market Overview
  • 29.2. Africa Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Somatic Genetic Testing Market Competitive Landscape And Company Profiles

  • 30.1. Somatic Genetic Testing Market Competitive Landscape
  • 30.2. Somatic Genetic Testing Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Somatic Genetic Testing Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. QIAGEN N.V.
  • 31.3. Exact Sciences Corp.
  • 31.4. ARUP Laboratories Inc.
  • 31.5. Natera Inc.
  • 31.6. Myriad Genetics Inc.
  • 31.7. Fulgent Genetics Inc.
  • 31.8. Invitae Corporation
  • 31.9. NeoGenomics Laboratories Inc.
  • 31.10. Guardant Health Inc.
  • 31.11. MedGenome Labs Ltd.
  • 31.12. Caris Life Sciences Inc.
  • 31.13. Oxford Nanopore Technologies Ltd.
  • 31.14. Pacific Biosciences of California Inc.
  • 31.15. Invivoscribe Inc.

32. Global Somatic Genetic Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Somatic Genetic Testing Market

34. Recent Developments In The Somatic Genetic Testing Market

35. Somatic Genetic Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Somatic Genetic Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Somatic Genetic Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Somatic Genetic Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer